Navigation Links
Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
Date:9/10/2007

ing.

Blue Cross Blue Shield of Massachusetts (BCBSMA) understands that implementing health information technology requires a level of commitment, financial support and buy-in from many levels of the healthcare community. With this understanding, BCBSMA implemented a suite of interventions. BCBSMA offers a reimbursement program for providers who use technology to provide e-visits (defined as online, non-urgent consultations between patients and the physicians).

Additionally, BCBSMA formed the e-Rx Collaborative with two other insurers. Collectively, the e-Rx Collaborative provides free e-prescribing devices, service(s) and software to more than 2,500 providers - one of the largest e-prescribing projects nationwide. During the first three and a half years, 10.8 million electronic prescriptions were transmitted through the Collaborative.

CareFirst BlueCross BlueShield collaborates with DrFirst, a healthcare software company, to equip 275 providers with an e-prescribing tool. Participating providers are given a wireless-enabled PDA (personal digital assistant) equipped with e-prescribing software to electronically send prescriptions to their patient's pharmacy. In 2006, participating providers registered a total of 550,000 prescription transactions that resulted in 15,000 drug interaction warnings and 7,400 drug allergy warnings being delivered to physicians. If some or all of these prescription transactions went unnoticed, the patient's health or life could have been jeopardized. CareFirst estimates that the warnings to physicians produced $1.6 million in savings.

Member Experience and Efficiency Improvements

WellPoint's client-facing programs use one of three separate data collection and documentation systems. Often times, communications between providers and the insurer are done by e-mail or fax. To help streamline this communication process, WellPoint developed the Member Activity Summary (MAS) Toolbar. The MAS Toolbar is a real-tim
'/>"/>

SOURCE Blue Cross Blue Shield Association
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)... 9 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: AD...lty pharmaceutical company,with operations in Chin...ceutical Inc., today announced that its consolidat...r 31, 2007, which were included in its,Annual Repo...ange,Commission on April 14, 2008, contained a ,go...
(Date:5/9/2008)... grain may provide protection against heart diseas...RLINGTON, Va., May 8 /PRNewswire/ -- Brown rice, a...d ranks of healthful whole grains, according,to an...g Administration,(FDA) that will allow brown rice ...This will enable consumers to easily identify brow...
(Date:5/9/2008)...f., May 9 /PRNewswire-USNewsire/ -- U.S.,corporati...elp victims of,the Cyclone Nargis in Myanmar are r... International, to ensure that the aid will reach ...It,s important to remember the complete story of t...with the people and organizations that,provide the...
(Date:5/9/2008)...RNewswire/ -- Summary: With the recent devastating...eaths and leaving over a,million people homeless, ...preneurs Sharon Tucci and Steve Jones have launche...ard awareness for humanitarian needs,with hopes o... initial goal,of having 1,000 individuals and comp...
Breaking Medicine News(10 mins):Health News:AMDL Reports Going Concern Qualification 2Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2Health News:New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals 2
...on an earlier discovery that a gene called IRF6 is... palate, researchers at the University of Iowa Roy...d their colleagues have identified the function of...e Oct. 15 in Nature Genetics, reveal an unexpected...
... of home care for several thousands of elderly peo...ectors.// According to the Commission for Social ...re givers too rushed, giving insufficient time to ...giving 15 minute slots of help, before moving on t...
...t government-sponsored reports released on Tuesday... in spite of the risks due to contamination. These.... "Overall, for major health outcomes among adult... outweigh the risks. Somehow, this evidence has be...
...accine has proved to be efficient on animals accor...ntario.// "Perhaps we can cure HIV infection. Th...sity of Western Ontario. Clinical trials of the va...i million to be invested by Curocom Co., a compan...
Other Medicine News:Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 3Health News:Standards of Home Care for Elderly Needs Change 2Health News:Eating Fish has more Benefits than Risks 2
(Date:5/7/2008)... Study to Evaluate Preferred Induction Dosing R...Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) toda...s, a,division of Wyeth (NYSE: WYE ), has commence...al of TRU-015 in patients with rheumatoid arthriti...aceuticals is developing,TRU-015, SBI-087 and othe...
(Date:5/7/2008)...INGTON, May 7 /- Shire plc ...opharmaceutical company, today,announced findings ...mine,treatment differences with DAYTRANA(TM) (meth...irls aged 6 to 12 years with Attention Deficit,Hyp...analysis reaffirmed,that DAYTRANA has an establish...
(Date:5/7/2008)...INGTON, May 7 /- Shire plc ...opharmaceutical company, presented,today at a majo...otal trial,results of INTUNIV, a selective alpha-2...e-daily medication, which is being evaluated for t...Hyperactivity Disorder,(ADHD). The data demonstrat...
(Date:5/7/2008)...BRUNSWICK, N.J., May 7 /- J...st for financial analysts on Friday, May 9,at 4:00... Pain Society,s,(APS) annual meeting in Tampa, Fla...tional tapentadol immediate release (IR), a novel ... for the first time at APS., A pre-recorded Webca...
Breaking Medicine Technology:Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 3Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6Mitchell Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research 3B Mitchell Endorses Ground Breaking Traumatic Brain Inj 823 1Mitchell Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research 3B Mitchell Endorses Ground Breaking Traumatic Brain Inj 823 2Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Sector Focus Conference 6020 1Novant Health Completes Purchase of MedQuest 6015 1Novant Health Completes Purchase of MedQuest 6015 2Novant Health Completes Purchase of MedQuest 6015 3HIV drug resistance risk in mothers reduced by combination of common drugs 6010 1HIV drug resistance risk in mothers reduced by combination of common drugs 6010 2
...Hematology and Oncology CHU Lapeyronie, Montpellie...se protein that has long been recognized as a mark...omplement a range of diagnostic markers to monitor...omic rationalization becomes a necessity throughou... areas of frequent laboratory testing may need car...
...Editor , Some form of electronic hematology ...aboratories. A blood cell count is usually the fir...ule out anemia or infection, and monitor cancer pa...fficult to imagine medical care without this workh...,, Early testing of sonar, developed to detect ...
Other Medicine Technology:Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 2Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 3
Angled shafts with 11 mm long tips. Jaws have longitudinal meshing serrations. Slide lock and serrated handle with polished finish.
Multi-curved shafts with straight blades and longitudinal serrations. Slide lock and serrated handle with polished finish. Blade length: 27 mm.
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish.
Smooth pointed tips open to 3.0 mm. 45 degree cross action angled shafts. Tip to Angle Length: 12.0 mm. Round handle.
Medicine Products: